Cigna Group 8-K

What Happened

• The Cigna Group (CI) announced on Feb. 25, 2026 that the Board appointed Brian C. Evanko as CEO, effective July 1, 2026. He will succeed David M. Cordani, who will retire as CEO and become Executive Chair on that date. The Board also increased its size to 12 members and elected Mr. Evanko as a director effective April 1, 2026. Mr. Evanko, 49, has served in senior Cigna roles including President & COO (since March 2025) and prior CFO and business unit leadership positions.
• The company reaffirmed its full‑year 2026 consolidated adjusted income from operations outlook of at least $30.25 per share, Evernorth pre‑tax adjusted income of at least $6.9 billion, and Cigna Healthcare pre‑tax adjusted income of at least $4.5 billion.

Key Details

• Leadership changes effective dates: Evanko named CEO effective July 1, 2026; elected director effective April 1, 2026; Board expanded to 12 members on April 1, 2026.
• CEO compensation (effective July 1, 2026): base salary $1,300,000; Enterprise Incentive Plan (EIP) target $2,600,000; Long‑Term Incentive (LTI) annual target $15,100,000 (60% Strategic Performance Shares, 25% restricted stock, 15% stock options). One‑time Transitional Equity Award target value: $3,500,000.
• David Cordani compensation as Executive Chair (effective July 1, 2026): base salary $1,000,000; EIP target $2,000,000; remains eligible for LTI. His 2026–2028 SPS award may continue to vest after retirement if he remains in service one year from grant and complies with post‑service covenants.
• Board leadership: Eric J. Foss elected Lead Independent Director effective April 1, 2026; Eric C. Wiseman will remain on the Board and transition to Chair of the Corporate Governance Committee.

Why It Matters

• This is a planned internal CEO succession that keeps leadership within Cigna’s current executive ranks, which may support continuity of strategy and operations. Investors should note the timing (July 1, 2026) and related board leadership changes that accompany the transition.
• Executive compensation changes are material to ongoing executive expense and equity dilution considerations (notably the large LTI targets and one‑time transitional award). The reaffirmed 2026 outlook gives investors management’s current performance targets, but the company notes these are non‑GAAP measures and forward‑looking, subject to risks and uncertainties.